• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19.

作者信息

De Wilton Angus, Nabarro Laura E, Godbole Gauri S, Chiodini Peter L, Boyd Aileen, Woods Katherine

机构信息

Hospital for Tropical Diseases, University College Hospitals London NHS Foundation Trust, London, United Kingdom.

Homerton University Hospital NHS Foundation Trust, London, United Kingdom.

出版信息

Travel Med Infect Dis. 2021 Mar-Apr;40:101981. doi: 10.1016/j.tmaid.2021.101981. Epub 2021 Jan 31.

DOI:10.1016/j.tmaid.2021.101981
PMID:33535106
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7847532/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de58/7847532/cdb5c29f4147/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de58/7847532/cdb5c29f4147/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de58/7847532/cdb5c29f4147/gr1_lrg.jpg

相似文献

1
Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19.在重症新型冠状病毒肺炎（COVID-19）患者中开具地塞米松处方时发生类圆线虫超感染综合征的风险。
Travel Med Infect Dis. 2021 Mar-Apr;40:101981. doi: 10.1016/j.tmaid.2021.101981. Epub 2021 Jan 31.
2
Dexamethasone and COVID-19: Strategies in Low- and Middle-Income Countries to Tackle Steroid-Related Strongyloides Hyperinfection.地塞米松与 COVID-19：中低收入国家应对类固醇相关强虫性感染的策略。
Am J Trop Med Hyg. 2021 Mar 15;104(5):1611-1612. doi: 10.4269/ajtmh.20-1085.
3
Reactivation of Strongyloides stercoralis in patients with SARS-CoV-2 pneumonia receiving dexamethasone.在接受地塞米松治疗的新冠病毒肺炎患者中粪类圆线虫的再激活
Med Clin (Barc). 2022 Mar 11;158(5):242-243. doi: 10.1016/j.medcli.2021.05.004. Epub 2021 May 27.
4
Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids.COVID-19 患者接受皮质类固醇治疗后的旋毛虫过度感染综合征。
Emerg Infect Dis. 2022 Jul;28(7):1531-1533. doi: 10.3201/eid2807.220198.
5
COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection.新型冠状病毒肺炎与地塞米松：一种避免类固醇相关类圆线虫超感染的潜在策略
JAMA. 2020 Aug 18;324(7):623-624. doi: 10.1001/jama.2020.13170.
6
Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.严重的新冠肺炎感染患者在接受免疫抑制治疗后出现了旋毛虫感染。
Infection. 2021 Jun;49(3):539-542. doi: 10.1007/s15010-020-01522-4. Epub 2020 Sep 10.
7
Influence of the drugs used in migrant patients with severe acute respiratory syndrome coronavirus 2 and the development of symptomatic strongyloidiasis.在患有严重急性呼吸综合征冠状病毒 2 的移民患者中使用药物的影响和症状性蠕形住肠线虫病的发展。
Trans R Soc Trop Med Hyg. 2022 May 2;116(5):440-445. doi: 10.1093/trstmh/trab152.
8
Successful use of subcutaneous ivermectin for the treatment of hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population.在免疫功能低下人群中，成功使用皮下注射伊维菌素治疗小肠梗阻和麻痹性肠梗阻情况下的重度感染。
BMJ Case Rep. 2018 Jun 4;2018:bcr-2017-223138. doi: 10.1136/bcr-2017-223138.
9
Diffuse alveolar haemorrhage and severe hypoxemia from Strongyloides stercoralis hyperinfection syndrome.粪类圆线虫高度感染综合征所致的弥漫性肺泡出血和严重低氧血症。
Clin Respir J. 2015 Oct;9(4):489-92. doi: 10.1111/crj.12169. Epub 2014 Jul 7.
10
Screening for strongyloidiasis in Spain in the context of the SARS-CoV-2 pandemic: Results of a survey on diagnosis and treatment.西班牙在 SARS-CoV-2 大流行背景下的旋毛虫病筛查：诊断和治疗调查结果。
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jun-Jul;41(6):329-334. doi: 10.1016/j.eimce.2022.08.006. Epub 2022 Aug 12.

引用本文的文献

1
Improving Molecular Epidemiological Surveillance of Strongyloidiasis Upon Differentiation of Strongyloides fuelleborni fuelleborni From Strongyloides stercoralis.在区分链状艾氏类圆线虫与粪类圆线虫后改进类圆线虫病的分子流行病学监测。
J Infect Dis. 2025 Jul 30;232(1):e169-e173. doi: 10.1093/infdis/jiaf237.
2
Strongyloides stercoralis infection in the UK: A systematic review and meta-analysis of published cases.英国的粪类圆线虫感染：已发表病例的系统评价和荟萃分析。
Clin Med (Lond). 2024 Jul;24(4):100227. doi: 10.1016/j.clinme.2024.100227. Epub 2024 Jul 14.
3
Answer to the Photo Quiz: Unexpected finding in a Gram stain.

本文引用的文献

1
Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.严重的新冠肺炎感染患者在接受免疫抑制治疗后出现了旋毛虫感染。
Infection. 2021 Jun;49(3):539-542. doi: 10.1007/s15010-020-01522-4. Epub 2020 Sep 10.
2
Case Report: Disseminated Strongyloidiasis in a Patient with COVID-19.病例报告：COVID-19 患者合并播散性粪类圆线虫病。
Am J Trop Med Hyg. 2020 Oct;103(4):1590-1592. doi: 10.4269/ajtmh.20-0699.
3
Dexamethasone: A boon for critically ill COVID-19 patients?地塞米松：对危重症COVID-19患者是福音吗？
图片测验答案：革兰氏染色中的意外发现。
J Clin Microbiol. 2023 Nov 21;61(11):e0064223. doi: 10.1128/jcm.00642-23.
4
Steroid-induced Strongyloidiasis with Cholestasis Post-COVID-19 Pneumonia.新冠病毒肺炎后类固醇诱导的类圆线虫病伴胆汁淤积
Oman Med J. 2023 Jul 31;38(4):e534. doi: 10.5001/omj.2023.31. eCollection 2023 Jul.
5
Prevalence of asymptomatic strongyloidiasis co-infection in COVID-19 patients residing in endemic areas.流行地区 COVID-19 患者中无症状类圆线虫合并感染的发生率。
Eur J Med Res. 2023 Aug 11;28(1):281. doi: 10.1186/s40001-023-01262-9.
6
Enhancing screening adherence for strongyloides infection in latinx inpatients with COVID-19: a local protocol implementation study.提高 COVID-19 住院拉丁裔患者中鞭虫感染的筛查依从性：一项本地方案实施研究。
Pathog Glob Health. 2024 May;118(3):232-240. doi: 10.1080/20477724.2023.2240088. Epub 2023 Jul 31.
7
Malabsorption due to strongyloidiasis after high-dose steroid therapy for Coronavirus disease-19.新型冠状病毒肺炎大剂量类固醇治疗后因类圆线虫病导致的吸收不良
Indian J Gastroenterol. 2025 Feb;44(1):118-119. doi: 10.1007/s12664-023-01378-0.
8
The Potential Nexus between Helminths and SARS-CoV-2 Infection: A Literature Review.寄生虫与 SARS-CoV-2 感染之间的潜在关联：文献综述。
J Immunol Res. 2023 Jun 20;2023:5544819. doi: 10.1155/2023/5544819. eCollection 2023.
9
Coinfection with and SARS-CoV-2: A Systematic Review.与……合并感染及新型冠状病毒肺炎：一项系统综述 （此处原文中“与……”部分内容缺失）
Trop Med Infect Dis. 2023 Apr 25;8(5):248. doi: 10.3390/tropicalmed8050248.
10
Strongyloides and COVID-19: Challenges and Opportunities for Future Research.类圆线虫与新型冠状病毒肺炎：未来研究的挑战与机遇
Trop Med Infect Dis. 2023 Feb 19;8(2):127. doi: 10.3390/tropicalmed8020127.
Travel Med Infect Dis. 2020 Sep-Oct;37:101844. doi: 10.1016/j.tmaid.2020.101844. Epub 2020 Aug 10.
4
COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection.新型冠状病毒肺炎与地塞米松：一种避免类固醇相关类圆线虫超感染的潜在策略
JAMA. 2020 Aug 18;324(7):623-624. doi: 10.1001/jama.2020.13170.
5
Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial.多剂量与单剂量伊维菌素治疗粪类圆线虫感染（Strong Treat 1 至 4）：一项多中心、开放标签、3 期、随机对照优效性试验。
Lancet Infect Dis. 2019 Nov;19(11):1181-1190. doi: 10.1016/S1473-3099(19)30289-0. Epub 2019 Sep 23.
6
Clinical and Diagnostic Features of 413 Patients Treated for Imported Strongyloidiasis at the Hospital for Tropical Diseases, London.413 例在伦敦热带病医院接受治疗的输入性类圆线虫病患者的临床和诊断特征。
Am J Trop Med Hyg. 2019 Aug;101(2):428-431. doi: 10.4269/ajtmh.19-0087.